Search

CBD - search results

If you're not happy with the results, please do another search

0 753

PotNetwork Holding, Inc. Wholly Owned Subsidiary Diamond CBD Takes in over $300,000 in Sales at CHAMPS Summer Show at the Las Vegas Convention Center

PotNetwork Holding, Inc. (OTC Pink: POTNis pleased to announce today that wholly owned subsidiary Diamond CBD was recently showcased at the CHAMPS Trade Show held at the Las Vegas Convention Center last week, and generated record-breaking results with orders reaching $300,000 over the 3 days featured at the event.

The CHAMPS Events have been regularly advantageous for Diamond CBD. The first two shows of the year, where the Company’s premium CBD hemp oils, edibles, and other specialty products were featured, yielded the Company valuable publicity, and record sales. The Summer Vegas Trade Shows are historically the second largest and second most attended CHAMPS shows of the year.

With the extent of publicity that Diamond CBD has been getting on a public level, along with the rate of consumer satisfaction and popularity, notable and distinguished sources have begun to take note, with PotNetwork being reviewed unsolicited, alongside other industry leaders by the likes of Forbes magazine online.

The trend of record-breaking quarters continues with strong momentum. Diamond CBD has reported that the past six months of trade show, expo, and convention attendance, demonstrating Management’s determined commitment to achieve strong results, yielded product demand requiring significant expansion of its manufacturing operations, which the Company is managing successfully. The Company plans to keep shareholders updated as events unfold with its new product lines, and other projects currently underway.

About the CHAMPS Trade Shows: Drawing exhibitors, entrepreneurs, and enthusiasts from across the country, this massive event is designed to enable vendors to unveil and market the industry’s newest cutting-edge products to distributors, wholesalers and retailers. The CHAMPS Trade Shows have been a staple in the counterculture industry for eighteen years, continually experiencing growth as the market continues to evolve. Since 1999, CHAMPS has hosted premier exhibitors in the industry and draws industry leaders, retailers and consumers in the thousands from all over the globe.

About Diamond CBD, Inc.: Diamond CBD focuses on the research, development, and multi-national marketing of premium hemp extracts that contain a broad range of cannabinoids and natural hemp derivatives. Diamond CBD’s team consists of hemp industry pioneers and natural product experts, chemists, and scientists, dedicated to producing the finest and purest cannabidiol (CBD) oils. The result is a robust selection considered among the most powerful natural CBD oils and E-Liquids found anywhere. For more information, please visit its website at www.DiamondCBD.com.

About PotNetwork Holding, Inc.: PotNetwork Holding, Inc. (OTC Pink: POTN) is a publicly traded company that acts as a holding company for its subsidiary, First Capital Venture Co., the owner of Diamond CBD, Inc., the maker of Diamond CBD oils.

Safe Harbor Act: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter forward-looking statements, whether as a result of new information, future events or otherwise.

0 756

Diamond CBD Brings Chill to CHAMPS Summer Show with Popular CBD Edibles and Top-Quality Oils

Showcased at Booth 8076, Diamond CBD Chill Gummies and Premium CBD Oils Make a Splash at the CHAMPS Trade Show and Gets Featured on PublicWire Podcast in Light of Recent Advancements

 PotNetwork Holding Inc. (OTC PINK: POTN) is pleased to announce today that wholly owned subsidiary, Diamond CBD, is presenting at the CHAMPS Trade Show held at the Las Vegas Convention Center this week, July 18-20th. The CHAMPS Trade Shows are widely recognized as the largest and most trusted counter-culture trade show in the world, and have always been particularly fruitful for Diamond CBD, with attendance in the thousands by buyers, enthusiasts and industry pioneers from all over the world.

Bruce Barren of PotNetwork Holdings, Inc. was also featured in an exclusive podcast interview with host Dave Donlin, where he focused on the Company’s record breaking revenues, sales distribution, possible future uplisting to a higher exchange and much more. To hear the interview in its entirety go to: http://www.publicwire.com/podcast/potnetwork-holdings-inc/

The Summer Vegas Trade Shows are historically the second largest and second most attended CHAMPS shows of the year. Located at the South Hall #1, off Paradise RD, this Champs show has held to the latest trend of record breaking attendance, following the last two shows that reported the highest attendance to date for each annual event.

The CHAMPS events have been regularly advantageous for Diamond CBD. The first two shows of the year, where the Company’s premium CBD hemp oils, edibles, and other specialty products were featured, yielded the Company valuable publicity, and record sales. Diamond CBD has recently reported that the past six months of trade show, expo, and convention attendance, demonstrating Management’s determined commitment to achieve strong results, had yielded product demand requiring significant expansion of its manufacturing operations, which the Company is managing successfully.

About the CHAMPS Trade Shows: Drawing exhibitors, entrepreneurs, and enthusiasts from across the country, this massive event is designed to enable vendors to unveil and market the industry’s newest cutting-edge products to distributors, wholesalers and retailers. The CHAMPS Trade Shows have been a staple in the counterculture industry for eighteen years, continually experiencing growth as the market continues to evolve. Since 1999, CHAMPS has hosted premier exhibitors in the industry and draws industry leaders, retailers and consumers in the thousands from all over the globe.

About Diamond CBD Inc.: Diamond CBD focuses on the research, development, and multi-national marketing of premium hemp extracts that contain a broad range of cannabinoids and natural hemp derivatives. Diamond CBD’s team consists of hemp industry pioneers and natural product experts, chemists, and scientists, dedicated to producing the finest and purest cannabidiol (CBD) oils. The result is a robust selection considered among the most powerful natural CBD oils and E-Liquids found anywhere. For more information, please visit its website at www.DiamondCBD.com.

About PotNetwork Holding Inc: PotNetwork Holding Inc. (OTC Pink: POTN) is a publicly traded company that acts as a holding company for its subsidiaries, First Capital Venture Co., the owner of Diamond CBD, Inc., the maker of Diamond CBD oils.

Safe Harbor Act: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter forward-looking statements, whether as a result of new information, future events or otherwise.

0 1102

“Guess Who’s Back?” PotNetwork Subsidiary Restocks Popular CBD Chill Gummies Inventory

PotNetwork Holding, Inc. (OTC Pink: POTNis pleased to announce that Diamond CBD’s Chill Gummy line has been restocked and is once again available for sale. “We are happy to announce that our popular Gummy Bears and other gummy edibles once again grace our shelves. As a result of an overwhelming influx of inquiries, we have opted to publicly announce that our gummies are stocked, available and ready to be shipped,” stated Maria Gomez, Regional Vice President of Sales, Diamond CBD.

Brought to market shortly after the Company’s inception, these tasty CBD Chill Gummiestook center stage, quickly evolving into one of the Company’s most popular and delectable signature treats. Diamond’s CBD infused Chill Gummy line has been restocked, making their whole spectrum of tantalizing flavors, such as the tasty Watermelon Slices, tart Sour Snakes, sprinkled Rainbow Bites, yummy Gummy Worms, tangy Sour Bears, quenching Ocean Gummies, chewy Gummy Rings, puckering Sour Faces and citrusy Mini Fruit, readily available once again for purchase on the Diamond CBD website.

PotNetwork Holding, Inc. recently announced that the highly productive road show brought on a wave of sales that even Management had not anticipated. Diamond CBD’s popular and highly sought-after Chill gummy line literally flew off the shelves, one flavor at a time. The past six months of trade show, expo, and convention attendance have demonstrated Management’s determined commitment to achieve strong results and product demand which required significant expansion of its manufacturing operations.

About Diamond CBD: Diamond CBD focuses on the research, development, and multi-national marketing of premium hemp extracts that contain a broad range of cannabinoids and natural hemp derivatives. Diamond CBD’s team consists of hemp industry pioneers and natural product experts, chemists, and scientists, dedicated to producing the finest and purest cannabidiol (CBD) oils. The result is a robust selection considered among the most powerful natural CBD oils and E-Liquids found anywhere. For more information, please visit its website at www.DiamondCBD.com.

About PotNetwork Holding, Inc: PotNetwork Holding, Inc. (OTC Pink: POTN) is a publicly traded company that acts as a holding company for its subsidiaries, First Capital Venture Co., the owner of Diamond CBD, Inc., the maker of Diamond CBD oils, and Sunrise Auto Mall Inc.

Safe Harbor Act: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter forward-looking statements, whether as a result of new information, future events or otherwise.

0 2377
marijuana-stocks-cannabis-CBDOIL

A great deal of progress is being made on learning how marijuana’s chemical cannabinoids can be used as medicine, and among the most interesting of these marijuana compounds is cannabidiol their wise known as CBD. It’s one of at least 113 active cannabinoids found in marijuana, it’s not responsible for marijuana’s psychoactive effect, and it accounts for about 40% of the marijuana plant’s extract.

At the forefront of research into CBD’s use as a medicine is GW Pharmaceuticals (NASDAQ: GWPH), a U.K. drug developer that currently markets a tetrahydrocannabinol (THC)-derived drug in Europe for the treatment of muscle spasms in multiple sclerosis patients.

Is CBD The True Medical Catalyst Of Marijuana?

GW Pharmaceuticals recorded data from three separate scientifically controlled tests this past year identifying that its purified CBD, Epidiolex, reduces seizures by about 40% in patients with rare forms of childhood-onset epilepsy, including Dravet syndrome and Lennox-Gastaut syndrome.

GW Pharmaceuticals’ findings back up anecdotal evidence that CBD heavy marijuana strains and oils provide relief to epilepsy patients. Perhaps the most well known of these high CBD strains is Charlotte’s Web, which has extremely low THC content (0.3%), and was named after the childhood epilepsy patient it was created to help.

In states that have passed medical marijuana legislation, growing evidence of cannabidiol’s efficacy in epilepsy patients is leading to greater availability at marijuana dispensaries. At last count, 28 states have passed medical marijuana laws, and 16 states have passed laws allowing the prescription of CBD oil.

Epidiolex isn’t commercially available yet, but it could be within a year. GW Pharmaceuticals hopes to file for Food and Drug Administration approval of Epidiolex soon, and an official decision would come within 10 months of that filing.

If Epidiolex becomes victorious in getting a regulatory green light, it will provide advantages to doctors and patients over CBD heavy marijuana strains and oils. While Epidiolex has been scientifically proven to work, the same rigorous proof isn’t available for CBD products like Charlotte’s Web that are sold at dispensaries. If Epidiolex is approved, it will be available nationally, regardless of each state’s laws, and that means it skirts risks associated with a federal crackdown on marijuana dispensaries by Washington. Furthermore, an FDA blessing would likely convince doctors who are otherwise hesitant to recommend medical marijuana to prescribe it.

0 4001
marijuana stock

Among the many segments of the marijuana industry that marijuana stock traders pay attention to, CBD or cannabidiol has taken on a major role. This is not only for its biotech-based applications but also for its uses outside of the health sciences sector. And with the growth that the market is projected t to see, CBD companies are definitely in the spotlight for the foreseeable future.

One Marijuana Stock that has been attracting the attention of marijuana investors has been Potnetwork Holdings, Inc. (POTN).  Now don’t let the name fool you, this company, through its subsidiary First Capital Venture Co., owns Diamond CBD Inc.;

Over the last few months, POTN has been breaking barriers with its CBD brand while also hitting major milestones for the better part of the first half of the year.  What could be best of all is that 2017 may already have the stage set for a record setting period in POTN’s company history.

Big Growth Already In Play?

In May of this year (2017) the company announced that it had realized first quarter figures that exceeded expectation by over $100,000, for a total of $1,858,347.48. They also established a merchandising pipeline of 7,000 authorized retail vendors through its distribution channels, which puts Diamond CBD at approximately 10,000 stores in the United States.

If this wasn’t enough, POTN further catapulted off of this first quarter momentum by recognizing over $2million from April to mid-May with a pace set to outshine the first quarter figure by a relatively large margin. Even assuming this rate of revenue generation and accounting for zero growth or contraction in revenues, POTN could be an $11million company by year’s end. Again this is assuming the company holds this course and does about $1million in revenue per month.

Let’s compare just by Revenue Figures Alone From Most Recent Annual Filings:

√ Medical Marijuana, Inc. 

$8.00m (Annual, 2016) Market Cap: $264.7M

√ Rocky Mountain High Brands, Inc.

$1.08m (Annual, 2016)   Market Cap: $ 53.4M

√ mCig, Inc.  

$4.5m (Annual, 2017)  Market Cap: $ 70.0M

√ Axim Biotechnologies, Inc.

$0.047m (Annual, 2016) Market Cap: $551.4M

Now look at these figures, the multiples are astronomical compared to their market caps:

  • mCig trades at roughly 15.5 times revenue
  • Medical Marijuana Inc. trades at nearly 33 times revenue
  • Rocky Mountain trades over 49.4 times revenue
  • Axim is trading at an astronomical 11,732 times revenue!

Now look at the same situation for Potnetwork. We can look at the 2016 annual for apples to apples comparison but the real story comes when you consider that Diamond CBD is now its subsidiary (which we’ll get into in a moment).

√ Potnetwork Holding, Inc.     

$1.03m    (Annual, 2016)   Market Cap: $38.2M

Even with last year being a slower year for the company, which could be attributed to the company’s future outlook and its uncertainty, Potnetwork had only traded at roughly 4 times revenue.

Now, let’s take into account the company’s last few months of announcements. By the figures given, it’s assumed that as of the end of May, Potnetwork revenue was in the ballpark of roughly $3.86m on a conservative estimate based on Q1 revenue and May revenues of over $1million: first quarter 2017 revenue of $1,858,347.48, “over $1 Million in April,” and “over $1Million for May.”

Price Target Given: $0.25

Being that this will be the first time that Diamond’s operations will be under the POTN flag, we can look at a brief snapshot of the company, at least from a first half standpoint of this year.

Even by just assuming that this company sees zero growth ahead and an outstanding share count of even 600m, at current prices of roughly $0.08, POTN would be a $48m market cap company with revenues of roughly $3.86m; only 12 times revenue.

But so far this year, a “zero growth” scenario has not been the case at all. In fact, based on recent announcements, growth for the company has been very pronounced so far. This is most likely a big reason why analysts are finding that the valuation for POTN is low right now. SeeThru Equity initiated coverage on Potnnetwork Holdings and recently gave a price target of $0.25. Meanwhile, the company continues to hit the convention circuit to build attention around the investment side of Potnetwork & Diamond CBD’s company as well as the actual product side of the business through countless tradeshow appearances.

And just recently the company announced that it has sold 80,000 Chill gummies since taking to the roadshow circuit. And currently POTN is “re stocking” over a two-week period to re-up its inventory of this brand.

The takeaway? In our opinion, compared to other presumed “industry leaders,” POTN is still trading at a fraction of the revenue multiple that these other companies are. Additionally, based on announcements, it doesn’t appear that the company, with Diamond CBD, is closing the doors and stopping its revenue growth anytime soon. This could be one of the more, if not the most undervalued CBD stocks in the market right now and the fundamentals show rapid growth projected along the way.

 “We are ecstatic with our results. We have learned to set our expectations high. As a result of the timing of CBD’s growing popularity and the quality of our products, our products are consistently met with reseller and consumer enthusiasm resulting in continuous escalating sales.”

-Maria Gomez, Regional Vice President of Sales for Diamond CBD, Inc.

The opportunity for taking advantage of the growth that CBD is beginning to see could be important to take into consideration.  Figures estimate that the CBD market will grow to a $2.1 billion market in sales by 2020. That’s a 700% increase from 2016.

Think about this for a moment: POTN is already growing and is expecting to continue this growth for the year, according to several announcements already made during the last few months…this is all going to happen during a time where the CBD industry as a whole is also anticipating significant growth.

Having already come off of a banner quarter, we think that preliminary guidance from the company would suggest that this is something to be paying close attention to during the second half of 2017.

 


Pursuant to an agreement between MAPH and Potnetwork Holdings, Inc., we were hired for a period of 1 month from 6/1/2017 – 7/1/2017 to publicly disseminate information about (POTN) including on the Website and other media including Facebook and Twitter. We are being paid $21,000 (CASH) by Potnetwork Holdings, Inc. via First Capital Ventures, Inc. an affiliate company for or “ZERO” shares of restricted or unrestricted common shares. We own zero shares of (POTN) which we purchased in the open market.We may buy or sell additional shares of (POTN) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

0 1112
Marijuana-Stocks-Cannabis-DEA

There are so many fronts in the war for marijuana legalization that it’s an arduous task to monitor all of them, yet the job has never been more important. And Last month, the Drug Enforcement Administration stealthy over-stepped its boundaries (again) and advanced its prohibitionist agenda. The mainstream media failed to report this, and it was through Technical 420’s own careful review of recently amended DEA codes that this was uncovered.

In October of 2016, the Cannabis Community was sent in to an uproar when the Department of Justice’s Drug Enforcement Administration tried to make CBD Oil’s illegal by redefining what constituted as marijuana extract under the “Final Rule establishing a new Controlled Substance Code Number (drug code) for marijuana extract”. You can read it here: https://www.deadiversion.usdoj.gov/fed_regs/rules/2016/fr1214.htm

The important part of the code can be found under ‘Final Action’ where it states: “Meaning an extract containing one or more cannabinoids that has been derived from any plant of the genus Cannabis, other than the separated resin (whether crude or purified) obtained from the plant.”

Essentially, last October, the DEA tried to categorize any extract from any part of the marijuana plant as a schedule one substance. This excluded extracts from resin or seeds, however, any other extract was a schedule 1 narcotic regardless of THC content.

Private companies, non-profits, and advocacy groups struck back with lawsuits claiming the law was over-reaching. And it seemed that the DEA backed off, and the cannabis community sighed a breath of relief.

However, sometime last month, the DEA quietly and unannounced posted an amendment to the code. The mainstream media, and even most CBD manufacturers, failed to pick it up this new posturing from the DEA. You can read it in full here:

https://www.deadiversion.usdoj.gov/schedules/marijuana/m_extract_7350.html

Under the “Clarification of the New Drug Code (7350) for Marijuana Extract” the definition of marijuana extract changes. While they do make changes to better structure their own legal grounds on the definition of what is marijuana extract, the important part of this updated code is that now anything extracted from marijuana is also included as a schedule one substance.

Just to highlight how absurd this is, consider that you can extract pure omega fatty acids from cannabis resin. No cannabinoids, no THC, just Omega (like 3, 6, & 9) Fatty Acids. The DEA literally just claimed that Omega Fatty Acids are a schedule 1 controlled substance when extracted from cannabis. Enough said.

To be as clear as their new rule is: Anybody selling CBD oil is now undoubtedly and unequivocally selling a schedule 1 substance. Seeds, while still not included in the code, are the only part of the cannabis plant that cannot produce quality CBD oils, just hemp oil.

It now is clear that their goal is to strengthen their positioning in their upcoming court battles over CBD’s scheduling classification. The updated code attempts to redefine CBD to include extracts and attempts to skirt around most of the legal claims of law suits already in the courts dockets. It’s an incredibly unethical and corrupt move.

Not to mention, these codes do not come from elected officials, but rather from bureaucratic actions that do not represent the American people. We will, of course, be keeping an eye on this latest development very closely.

Authored By: Jason Spatafora

0 601

INCC Enters Into an Exclusive License Agreement for a CBD Formulation Focused on Enhancing Cognitive Function in Adults

International Consolidated Companies, Inc. (INCC) announced today it entered into an exclusive license agreement with CBD Medicinals, LLC for a patent application and trade secrets surrounding the development of an over the counter cannabidiol (CBD) formulation to improve cognitive function in adults.

This technology included novel combinations of CBD, mushroom derived hericenones, and neurotransmitter precursors. Both hericenones and CBD are known to have neuro-protective and neuro-regenerative effects in vivo.

“This will allow us to develop designer CBD products focused on niche markets where the demand is high,” said Antonio Uccello, President INCC.

International Consolidated Companies (INCC) was founded in 2002. INCC is focused on acquiring and producing innovative, high quality, and cost-efficient cannabis technologies.

Forward-looking disclaimer

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material may contain statements about expected future events and/or financial results that are forward-looking in nature and subject to risk and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements to be materially different from the statements made herein.

More Information:
Antonio F. Uccello
INCC
720-460-0734
baltic38dp@me.com

http://www.element79.us

@StJamesRx

@BluDogProducts

0 1298

Hemp, Inc. to Plant Over 550 Acres of CBD-Rich Hemp Plants

The company also plans on purchasing its second CBD Extractor this year. As announced in Hemp, Inc.’s last press release, the company has already purchased its first industrial NuAxon Tech CO2 Supercritical extractor from NuAxon BioScience, the manufacturer and producer of the world class, large capacity CO2 Supercritical Extraction equipment. However, with the industry’s expanding CBD market and ever-increasing consumer CBD sales over the past few years, executives feel it is in the best interest of its shareholders to acquire a second extractor to capture a solid, sizeable share of the market while still in the early growth stage.

The CBD market is expected to “grow to a $2.1 billion market in consumer sales by 2020 with $450 million of those sales coming from hemp-based sources. That’s a 700% increase from 2016. In 2015, the market for consumer sales of hemp-derived CBD products was $90 million, plus another $112 million in marijuana-derived CBD products which were sold through dispensaries — bringing a total CBD market to $202 million last year,” according to Forbes.com.

David Schmitt, COO of Hemp, Inc.’s wholly owned subsidiary, Industrial Hemp Manufacturing, LLC (IHM), said they have been researching CBD extraction methods and manufacturers for the past 2 years, weighing the pros and cons of both. For its second CBD extractor purchase, executives found another manufacturer they feel would produce another superior CBD extractor that utilizes a different technology. Based on Hemp, Inc.’s research, building a CBD extractor takes extensive testing, product knowledge and continual process improvement to ensure a superior product that is held to the highest of standards. A collaborative design engineering team that ensures the quality of each component, coupled with a customizable approach, guarantees the extractor will meet all of Hemp, Inc.’s specifications and standards.

Schmitt expects both extractors to have optimized production levels. “The CO2 Supercritical Extractor that is currently in-house is expected to be assembled over the next 3 months. Once assembled, we will be ready to process and extract CBD oil,” said Schmitt.

Bruce Perlowin, CEO of Hemp, Inc. ( OTC PINK : HEMP ) said, “The CBD market has been growing by leaps and bounds. CBD’s medicinal qualities have been making waves across America. Residents in states that have not legalized medical marijuana are finding that CBDs from hemp are an alternative to pharmaceutical drugs to treat debilitating medical conditions. There have been recent studies showing CBDs are preferred over addicting pharmaceutical drugs.”

Earlier this year, the National Academies of Science, Engineering, and Medicine (NASEM) released a comprehensive report regarding cannabis’ health benefits. The study confirmed substantial evidence that cannabis is useful in the treatment of some common and severe medical ailments such as chronic pain, multiple sclerosis, and chemotherapy-induced nausea and vomiting. It was also interesting to note that pharmaceutical companies have started creating cannabis-like drugs for multiple sclerosis, nausea and vomiting. While the pharmaceutical alternative, CBD, is viewed as a more appealing option, it is often expensive and not readily available to patients.

The pharmaceutical choices, such as prescribed opioid pain medications, are addictive and users are at high risk of fatal overdose.

Cannabidiol (CBD) is the part of the cannabis plant that has significant medical benefits, but does not make people feel “high” and can even counteract the psychoactivity of THC (that part that does make people feel “high”). Since CBDs are non-psychoactive, it’s an appealing option for medical patients seeking alternative ways to relieve conditions such as inflammation, pain, anxiety, psychosis, seizures, and spasms, without disconcerting feelings of lethargy.

0 3011
marijuana-stocks-cannabis-CBDOIL

The emergence of the legal cannabis industry has created an unprecedented opportunity for investors. Although this burgeoning industry is already a multi-billion-dollar business, it is not even in the first inning of what will be multi-decade growth super cycle.

The biotech industry will be one of the greatest beneficiaries of the legal cannabis industry. From Israel to the United States, the number of studies on the medical benefits of cannabis continues to increase and to provide exciting results.

The cannabis plant has over 100 known chemical compounds but the two best known are cannabidiol (CBD) and tetrahydrocannabinol (THC). Although CBD has a much shorter history than THC, recent research studies have significantly increased our understanding of its medical benefits and its popularity continues to grow.

CBD is an appealing option for patients who are looking to treat ailments such as pain, anxiety, psychosis, seizures, spasms, to just name a few. It also does not have the primary psychoactive ingredient found in THC, which gets the user high.

A Miracle Plant with Endless Benefits

Cannabis has the potential to treat countless debilitating conditions. From epilepsy to multiple sclerosis, cannabis can improve daily life for millions of people across the globe and we need to recognize it for what it is, a medicine. Unlike other pharmaceutical drugs such as opiates or benzodiazepines, cannabis does not require you to take another type of drug to combat its side effects.

Although medical cannabis still has a way to go before it will be accepted as a medical treatment, there have been several developments with regard to its medical benefits and we want to highlight five of the known benefits of CBD.

Epilepsy

Over the last two years, we have heard some incredible stories from the parents of children who were having more than 300 seizures a day. These children were being prescribed large doses of prescription drugs such as benzodiazepine, which did not solve the problem and had a negative impact on the child’s demeanor.

The growing number of research studies and stories from the parents of children who have benefited from CBD have led to an influx in the number of parents using CBD as a treatment. Many parents have said that CBD is an effective treatment that has reduced the frquency of daily seizures by more than 95%.

The benefits that CBD has had for patients with epilepsy has been a catalyst for the legal cannabis movement as we have seen a significant increase in the number of states with a limited medical cannabis market, which allow only strains with very low THC and high CBD.

Crohn’s Disease

Researchers and scientists have said CBD could be an effective treatment for Crohn’s Disease. In 2015, researchers in Israel conducted a study which reported significantly lower symptoms in 10 out of 11 patients with Crohn’s disease. The study said five of those patients saw a complete remission from the treatment.

Many researchers talk about the entourage effect and how cannabis works best as a medical treatment when all molecules in cannabis are present, even in a very minor capacity (less than 0.1%). When it comes to Crohn’s, it has been found that the interaction of THC and CBD helps control stomach functions, a major benefit for Crohn’s patients. Cannabis has an anti-inflammatory component providing relief to those suffering from Crohn’s.

Post-Traumatic-Stress-Disorder (PTSD)

One of the major benefits of CBD is its ability to produce anti-anxiety and anti-inflammatory effects when ingested. This is very helpful for patients who suffer from PTSD since it slows everything down (including the mind) and calms the user.

People suffering from PTSD can become overcome with anxiety and stress and anecdotal evidence shows that CBD can help treat these symptoms. The antipsychotic benefits of CBD provide relief to patients in need of a more stable emotional environment.

Pain

One of the most well-known and well-documented medical benefits associated with cannabis is its ability to treat pain. In 2011, researchers said that cannabis may help relieve pain for people suffering from rheumatoid arthritis.

CBD can help reduce pain associated with a wide variety of illnesses and debilitating diseases. From cancer to fibromyalgia, from irritable bowel syndrome to neuropathic pain, CBD can help throughout the treatment and the recovery process.

Multiple Sclerosis

Nasdaq-traded GW Pharmaceuticals’ (GWPH) developed and commercialized Sativex, the world’s first cannabis-derived product for the treatment of spasticity due to multiple sclerosis. Sativex is sold in 29 countries and is also being developed as a treatment for neuropathic pain (in Phase 2 Clinical trials).

0 675

Rocky Mountain High Brands Announces CBD-Infused Flavored Waters and CDB-Infused Flavored Energy Drinks and Beverages

Rocky Mountain High Brands, Inc. (RMHB), a fully reporting consumer goods company specializing in hemp-infused food and beverage products and a naturally high alkaline water, announced today that it will soon start producing a line of both Cannabidiol (CBD) infused flavored waters and CBD-infused flavored energy drinks and beverages.

Michael Welch, President and Chief Executive Officer of Rocky Mountain High Brands, stated, “Our new Blueleaf CBD-Infused flavored water product line will be produced in the next 30 days and will available for purchase this summer. We will be offering three flavors of Blueleaf CBD-Infused flavored water – Water Cucumber, Lemon/Lime and Watermelon.”

Welch continued, “Next week, we will start focus groups to help the Company with the packaging and the positioning of the CBD-infused flavored energy drinks and beverages.  Our goal is to be the leader in CBD energy drinks.  With the guidance of Gerry David and the marketing expertise of Kevin Harrington, we believe that we can build a strategy to achieve that goal.”

About Rocky Mountain High Brands:

ROCKY MOUNTAIN HIGH BRANDS, INC., is a consumer goods company specializing in brand development of health conscious, hemp-infused food and beverage products. The Company currently markets a lineup of four naturally flavored hemp-infused beverages (Citrus Energy, Black Tea, Mango Energy and Lemonade) and a low calorie Coconut Lime Energy drink. Rocky Mountain High Brands also offers hemp-infused 2oz. Mango Energy Shots and Mixed Berry Energy Shots. The Company recently launched a naturally high alkaline spring water, Eagle Spirit Spring Water.

For interested investors, our stock symbol is RMHB.

For ordering information please visit: LiveRockyMountainHigh.com

For corporate information please visit: RockyMountainHighBrands.com

For information on our high alkaline water visit: EagleSpiritWater.com

For Rocky Mountain High Distribution Contact:

Chuck Smith (972) 955-0964
chuck@rockymountainhighbrands.com

Download the Rocky Mountain High App:

https://play.google.com/store/apps/details?id=com.app_rmhigh.layout&hl=en

Visit us on Facebook:
https://www.facebook.com/rockymountainhighbrands?fref=nf

Visit us on Twitter:
#GetYourHempOn

Visit us at Investors Hangout: http://investorshangout.com/Rocky-Mountain-High-Brands-Inc-RMHB-69150/

Investors Hangout is the only authorized Investors blog page for Rocky Mountain High Brands, Inc.

Safe Harbor Act: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involves risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic business conditions and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.

Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Marijuana Stocks, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com
Ad Placements